On Nov 19, 2025, Nasdaq notified Avalon GloboCare (ALBT) it is not in compliance with Listing Rule 5550(b) due to stockholders' equity of ($3,891,270) vs required $2.5M.
The company had until Nov 18 to regain compliance after a May 2025 deficiency notice; failure to do so led to the delisting notification.
Trading of ALBT common stock is subject to suspension/delisting unless the company timely requests a hearing before the Nasdaq Hearings Panel.
The company plans to request a hearing, which will automatically stay any suspension/delisting action pending the hearing and any extension granted.
This disclosure is required under Nasdaq Listing Rule 5810(b).
Avalon GloboCare Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
stockholders equity
Rules
5550(b)(1)
Exact text from the filing
November 19, 2025, the Company received a letter (the “November Nasdaq Letter”) from Nasdaq indicating that the Company was not in compliance with Listing Rule 5550(b). Unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”), trading of the Company’s common stock would be subject to suspension/delisting. Accordingly, the Company plans to timely request a hearing before the Panel, which request will automatically stay any suspension or delisting action by Nasdaq pending the hearing and the expiration of any additional extension period granted by the Panel fol
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.